Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 15, 2017, after the close
10-Q filed May 15, 2017, 45 days after period end · 0000320017-17-000040
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 |
|---|---|---|---|---|
| Revenue | $7.92M | $7.49M | $3.17M | $4.06K |
| Net Income | -$9.79M | -$12.05M | -$19.19K | -$13.68K |
| EPS Diluted | -$1.12 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$2.09 |
| -$0.51 |
| -$0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
